Single-Photon Emission Computed Tomography (SPECT) is a nuclear medicine imaging technique primarily used to assess functional abnormalities and blood flow status of human organs. After injection of a radioactive isotope, the device captures differences in tissue absorption of radiation, forming three-dimensional images that assist physicians in diagnosing diseases of the heart, brain, and bones. Unlike CT or MRI, SPECT's advantage lies in displaying organ metabolic activity and blood flow dynamics, often combined with anatomical imaging techniques.
This technology is especially sensitive to functional lesions in clinical applications, such as early detection of myocardial ischemia or localization of epileptic foci in the brain. The examination duration ranges from approximately 30 minutes to several hours, depending on the site and type of radiotracer used. The entire process is painless and non-invasive.
SPECT mainly includes cardiac SPECT, brain SPECT, and skeletal SPECT. Its mechanism involves injecting a radioactive isotope (e.g., Technetium-99m) intravenously, which is absorbed in varying amounts by different tissues based on metabolic activity or blood flow differences. The detector rotates around the patient, receiving gamma rays emitted by the isotope, and reconstructs three-dimensional images to display abnormal regions of organ function.
Compared to Positron Emission Tomography (PET), SPECT uses isotopes with shorter half-lives and is less costly, but with slightly lower spatial resolution. This characteristic makes it the standard examination for assessing blood flow dynamics (such as myocardial perfusion), especially in outpatient settings.
In cardiology, indications include evaluating the extent of myocardial ischemia in angina patients, monitoring treatment effects of coronary artery disease, and excluding diagnoses in patients with acute chest pain. In neurology, it is used for localizing seizure sources, early screening for Alzheimer's disease, and assessing cerebral blood flow abnormalities post-stroke.
In the skeletal system, applications include staging primary or metastatic bone tumors, localizing causes of unexplained bone pain, and evaluating inflammatory activity in rheumatoid arthritis. Additionally, it can analyze glomerular filtration function and blood flow distribution in kidney diseases.
Fasting for 4-6 hours prior to the exam is required, and patients should inform the physician if pregnant or breastfeeding. The radiotracer dose depends on the site of examination; for example, cardiac SPECT typically uses approximately 7-11 mCi of Technetium-99m Tc-sestamibi, with a total absorbed dose lower than that of standard X-ray examinations. Patients should lie still and remain immobile for 15-60 minutes; in special cases, pharmacologic stress testing (such as adenosine injection) may be performed to induce myocardial ischemia.
Dosage follows the ALARA (As Low As Reasonably Achievable) principle, with adjustments made for children or patients requiring repeated scans. Post-examination, drinking plenty of water is recommended to accelerate radiotracer excretion. The radioactive substances are usually fully metabolized within 24-48 hours.
In terms of cost-effectiveness, SPECT has lower operational costs compared to PET scans and offers unique advantages in diagnosing cardiac and neurological diseases, often serving as an initial screening tool in outpatient settings.
The main risk is radiation exposure; however, the total dose from a single scan is approximately equivalent to the background radiation received over 3-6 months in the natural environment. A small number of patients may experience allergic reactions to the radiotracer components, such as rash or difficulty breathing, requiring allergy history assessment before the procedure.
Special risk groups: Pregnant women may be affected and should avoid the procedure strictly; patients with thyroid disease need dose adjustments when using iodine-containing radiotracers; severe renal impairment may prolong the metabolism of radioactive substances, increasing tissue accumulation risks.
Within 24 hours after the scan, avoid close contact with pregnant women or infants. Clothing should be washed to remove residual radioactivity.
SPECT itself does not directly interact chemically with medications, but attention should be paid to timing between radiotracer and other drugs: for example, diuretics may accelerate radioactive excretion, affecting image quality; diabetic patients injected with glucose-based tracers may have altered results.
In treatment planning, SPECT results are often combined with decisions on coronary angioplasty or preoperative brain localization. Patients should inform their physicians of all medications they are taking.
In cardiology, multicenter studies show that SPECT has a diagnostic accuracy of 89% for myocardial ischemia, superior to the 65% accuracy of electrocardiography. A 2018 JAMA study indicated that combining SPECT with CT increases the sensitivity of detecting tumor metastases by 30%.
In epilepsy assessment, combining SPECT with EEG improves lesion localization accuracy and is a standard preoperative evaluation for epilepsy surgery. Long-term follow-up studies show that SPECT-guided treatment plans can reduce misdiagnosis rates by 30%.
If patients are contraindicated for radiation exposure, alternatives include:
• Cardiac ultrasound: radiation-free but limited in functional assessment
• Tumor-targeted ultrasound: insufficient resolution for deep lesions
• Brain Positron Emission Tomography (PET): higher resolution but more costly
If radiation exposure is to be avoided, CT perfusion imaging or MRI functional imaging can be alternatives, though their functional assessment specificity is lower than SPECT. The choice should be based on lesion depth, organ metabolic characteristics, and available medical resources.
It is recommended to avoid iodine-containing foods or drinks, such as seafood and iodized salt, 24 hours before the exam. If taking potassium or calcium supplements, inform the healthcare staff in advance for adjustment. On the day of the scan, wear comfortable clothing and avoid wearing metal jewelry to prevent interference with image clarity.
Can I move or ventilate if I feel nervous or dizzy during the scan?The scanner space is relatively small and enclosed. If feeling unwell, immediately notify staff via the built-in intercom. Although the scan lasts about 30-60 minutes, adjustments or pauses can be made as needed. Medical staff will assess whether additional ventilation or short breaks are necessary. Please communicate your needs proactively.
Do I need to adjust my medication after the scan?If using radioactive tracers, it is recommended to drink plenty of water within 24 hours to facilitate metabolism, but routine medications generally do not need to be stopped. If undergoing kidney or liver treatments, follow medical advice and observe urine color changes, reporting any abnormal symptoms such as persistent nausea or difficulty urinating within 24 hours.
How do I interpret abnormal results, and when is immediate treatment necessary?Abnormal reports are categorized into "urgent follow-up" and "regular observation." If there is significant blood flow deficiency or abnormal metabolic accumulation, the physician will recommend secondary examinations such as angiography or tissue biopsy based on medical history and symptoms. Patients should bring all previous examination reports to assist in evaluating changes.
When can I resume normal activities after a SPECT scan?Normal diet and light activities can be resumed immediately after the scan, but it is advised to avoid driving or operating delicate machinery for the day. If the scan involved the heart or brain, avoid strenuous exercise for 24 hours and monitor for dizziness or muscle soreness. It is recommended to discuss the results and follow-up steps with your physician within 72 hours.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
